AREDS2
Showing 1 - 25 of 66
Age-Related Eye Disease Study (AREDS) Follow-Up
Active, not recruiting
- Age-Related Macular Degeneration
- Cataract
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Non-Exudative (Dry) Age-related Macular Degeneration (dAMD) Trial (EG-301, AREDS2 supplements)
Not yet recruiting
- Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
- EG-301
- AREDS2 supplements
- (no location specified)
Jul 27, 2022
Blood and Saliva Sample Collection for AREDS 2
Completed
- Age-Related Macular Degeneration
- Eye Diseases
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 26, 2019
Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On
Completed
- AMD
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 22, 2019
Retinal Drusen, Age-related Macular Degeneration, Macular Degeneration Trial in Austin (Lumega-Z, AREDS2)
Completed
- Retinal Drusen
- +2 more
- Lumega-Z
- AREDS2
-
Austin, TexasEye Clinic of Austin
May 9, 2019
Glaucoma, Glaucoma Eye, Glaucoma, Open-Angle Trial in San Antonio (dietary supplement, drug, other)
Withdrawn
- Glaucoma
- +2 more
- Lumega-Z
- +2 more
-
San Antonio, TexasOphtalmology Clinic of William E Sponsel
Sep 30, 2022
Age-related Macular Degeneration Trial in Chicago (Resveratrol, Quercetin, Curcumin (RQC), Curcumin)
Recruiting
- Age-related Macular Degeneration
- Resveratrol, Quercetin, Curcumin (RQC)
- Curcumin
-
Chicago, IllinoisZaparackas M.D. & Knepper M.D. Ph.D., Ltd
Sep 20, 2021
Objective Choroidal Thickness Measurements in Uveitis
Active, not recruiting
- Uveitis
-
Wrocław, PolandDepartment of Ophthalmology
Mar 27, 2022
Sleep Apnea, Glaucoma, Ocular Hypertension Trial in Wroclaw
Active, not recruiting
- Sleep Apnea
- +2 more
-
Wrocław, PolandDepartment of Ophthalmology
Mar 27, 2022
VeriSee AMD in Screening for Age-Related Macular Degeneration
Completed
- Macular Degeneration, Age Related
- Maculopathy, Age Related
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 23, 2022
Generation of Induced Pluripotent Stem Cell Lines From Skin
Completed
- AMD
-
Beverly Hills, California
- +13 more
Apr 3, 2019
AMD, Soft Drusen, Reticular Pseudodrusen Trial in Barcelona (Postbotics and Vitamins, Vitamins)
Recruiting
- AMD
- +4 more
- Postbotics and Vitamins
- Vitamins
-
Barcelona, SpainInstitut de la Macula
Sep 14, 2021
Mitochondrial DNA in Vitreous Fluid and Blood in Eye Disease or
Withdrawn
- Eye Diseases
- +5 more
- Sample collection from tissue discard
- (no location specified)
Jan 30, 2023
Macular Degeneration Trial in North Chicago, Oak Lawn (EyePromise Visual Edge)
Completed
- Macular Degeneration
- EyePromise Visual Edge
-
North Chicago, Illinois
- +1 more
Feb 3, 2021
Age-related Macular Degeneration Trial in Coimbra (Blood draw and urine collection)
Completed
- Age-related Macular Degeneration
- Blood draw and urine collection
-
Coimbra, PortugalAIBILI
Jan 6, 2023
Uveitis Trial in Wroclaw (Surveillance card)
Recruiting
- Uveitis
- Surveillance card
-
Wrocław, PolandDepartment of Ophthalmology
Apr 16, 2021
Wet Macular Degeneration Trial in Portugal, Spain (Retilut, Theavit)
Completed
- Wet Macular Degeneration
- Retilut
- Theavit
-
Celas, Coimbra, Portugal
- +8 more
Feb 11, 2021
High Resolution Optical Coherence Tomography
Not yet recruiting
- Retinal Disease
- +15 more
- High-resolution optical coherence tomography (High-Res-OCT)
- Standard spectral domain OCT (SD-OCT)
-
Bern 3010, Bern, SwitzerlandDepartment of Ophthalmology, Bern University Hospital, Bern, 301
Nov 17, 2021
Contact Lens Complication Trial in Valladolid (Aquoral Lipo (Esteve), Hyabak (Thea))
Recruiting
- Contact Lens Complication
- Aquoral Lipo (Esteve)
- Hyabak (Thea)
-
Valladolid, SpainIOBA - University of Valladolid
Nov 28, 2022
GARM II: A Study on the Genetics of Age-related Maculopathy
Active, not recruiting
- Age-related Macular Degeneration
- Age-related Maculopathy
- Observational-1
- Observational-2
-
Los Angeles, California
- +1 more
May 16, 2022
Constrast Sensitivity Trial (Carotenoids supplementation, Placebo)
Not yet recruiting
- Constrast Sensitivity
- Carotenoids supplementation
- Placebo
- (no location specified)
Oct 19, 2023
Macular Degeneration Trial in United Kingdom (Epimacular Brachytherapy, Ranibizumab)
Completed
- Macular Degeneration
- Epimacular Brachytherapy
- Ranibizumab
-
Exeter, Devon, United Kingdom
- +23 more
Nov 23, 2020
Neovascular Macular Degeneration Trial in Worldwide (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321), Visudyne)
Completed
- Neovascular Macular Degeneration
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
- Visudyne
-
Liverpool, New South Wales, Australia
- +61 more
Nov 17, 2020
Wenzhou Dry Age-related Macular Degeneration Progression Study
Recruiting
- Macular Pigment Optical Density
-
Wenzhou, Zhejiang, ChinaThe eye hospital of Wenzhou Medical University
Feb 23, 2021